US Patent Issued to CNG Bio on Feb. 3 for "Process for preparing isoindolinone derivative, novel intermediates used for the process, and a process for preparing the intermediates" (South Korean Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,123, issued on Feb. 3, was assigned to CNG Bio Co. Ltd. (Chungcheongbuk-do, South Korea).

"Process for preparing isoindolinone derivative, novel intermediates used for the process, and a process for preparing the intermediates" was invented by Jae-kyung Jung (Chungcheongbuk-do, South Korea), Mi Kyeong Lee (Chungcheongbuk-do, South Korea), Vishwanath Manjunatha (Chungcheongbukdo, South Korea), Dae-Hee Lee (Chungcheongbuk-do, South Korea) and Jae-Kang Lee (Chungcheongbuk-do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a process for preparing an isoindolinone derivative represented by Formula 1, novel inte...